Leadership Overview
PAI Pharma has 4 executives leading key functions including strategy, financial oversight, operational management, and business development.
Committed to advancing patient-centric drug delivery, PAI Pharma maintains a rigorous focus on manufacturing high-quality generic oral liquid medications and unit-dose solutions for the United States healthcare market.
Committed to advancing patient-centric drug delivery, PAI Pharma maintains a rigorous focus on manufacturing high-quality generic oral liquid medications and unit-dose solutions for the United States healthcare market.
Leadership Roles at PAI Pharma
Kurt Orlofski - Chief Executive Officer
Kurt Orlofski, the Chief Executive Officer at PAI Pharma, directs the overarching corporate strategy and long-term vision for the organization. By prioritizing the development of generic oral liquid medications, Orlofski ensures the company maintains a competitive edge within the United States healthcare market. The Chief Executive Officer manages high-level relationships with institutional healthcare providers and government agencies to expand market reach. Through constant evaluation of manufacturing capabilities, Orlofski drives the production of high-quality suspensions and syrups. This leadership role involves aligning internal resources with the evolving needs of retail pharmacy chains and long-term care facilities. By fostering a culture of operational excellence, Kurt Orlofski secures the company's position as a leader in patient-centric drug delivery solutions. Ultimately, the Chief Executive Officer guarantees that all pharmaceutical manufacturing processes meet stringent quality standards while supporting sustainable growth across the entire domestic portfolio.
Debra Cesard - Chief Financial Officer
Debra Cesard, the Chief Financial Officer at PAI Pharma, manages the fiscal health and capital allocation strategies for the organization. Overseeing financial planning and analysis, the Chief Financial Officer ensures the company maintains the necessary liquidity to support large-scale manufacturing of unit-dose pharmaceuticals. Cesard directs the budgeting processes for research, development, and distribution of prescription generic medicines. By monitoring market trends in the United States, the Chief Financial Officer optimizes cost structures for injectable medicines and semi-solid formulations. This leadership role requires close collaboration with the executive team to evaluate investment opportunities in new drug delivery technologies. Debra Cesard provides the financial oversight required to sustain operations across acute care facilities and independent pharmacies. Through rigorous risk management and financial reporting, Cesard strengthens the economic foundation of the company, ensuring long-term stability and continued investment in high-quality pharmaceutical manufacturing.
Brandon Rockwell - President & Chief Operating Officer
Brandon Rockwell, the President & Chief Operating Officer at PAI Pharma, executes the daily manufacturing and supply chain operations for the company. Managing the production of oral solutions and elixirs, the President & Chief Operating Officer ensures seamless distribution to retail pharmacy chains and institutional providers. Rockwell oversees the technical aspects of pharmaceutical packaging and quality control to maintain compliance with industry regulations. By streamlining internal workflows, the President & Chief Operating Officer increases efficiency in the manufacturing of generic medications. This leadership role involves coordinating with logistics teams to ensure timely delivery of products to long-term care facilities throughout the United States. Brandon Rockwell drives the implementation of advanced manufacturing technologies to enhance the output of syrups and suspensions. Through constant process improvement, Rockwell optimizes the operational scale of the organization, directly supporting the company's mission to provide reliable, high-quality pharmaceutical products to the healthcare sector.
Michael Elliott - President
Michael Elliott, the President at PAI Pharma, leads the commercial expansion and business development initiatives for the organization. Focusing on the growth of the over-the-counter and prescription generic portfolio, the President identifies new market opportunities within the United States healthcare system. Elliott directs the sales strategy to increase the presence of unit-dose pharmaceuticals in acute care facilities and government agencies. By analyzing customer requirements, the President ensures the product lineup meets the specific needs of retail pharmacies and institutional providers. This leadership role involves building strategic partnerships to broaden the distribution of specialty pharmaceutical formulations. Michael Elliott manages the commercial team to drive revenue growth and market penetration for oral liquid medications. Through proactive engagement with healthcare stakeholders, Elliott strengthens the brand presence of the company, ensuring that the organization remains a preferred partner for high-quality, patient-centric drug delivery solutions across the entire country.
Explore Leadership Teams in Manufacturing
Zoetis discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. The company offers vaccines, medicated feed additives that offer medicines to livestock; and other pharmaceutical products, which comprise allergy and dermatology, pain and sedation, antiemetic, reproductive, and oncology products. It markets to veterinarians, livestock producers, and retail outlets, as well as third-party veterinary distributors through its sales representatives, and technical and veterinary operations specialists. The company is headquartered in Parsippany, New Jersey.
Company Leadership LP
RV
SA
MT
Founded in 1954 and headquartered in Suresnes, France, Servier international is an independent pharmaceutical company governed by a non-profit foundation. Their three research centres are continuously involved in creating, testing, and developing new medicinal products, which are manufactured and packaged in their production centres around the world.
Company Leadership AA
VT
KP
Emcure Pharmaceuticals Limited is a global pharmaceutical company engaged in the research, development, manufacturing, and marketing of a broad range of pharmaceutical products and healthcare solutions. Headquartered in Pune, India, the organization operates as an international pharmaceutical enterprise with a strong presence in both domestic and global healthcare markets. The company focuses on delivering innovative and affordable medicines that address a wide spectrum of medical conditions and therapeutic needs across the healthcare sector. The organization is driven by a research-focused strategy that emphasizes innovation, scientific advancement, and the development of effective therapeutic solutions. Through its research and development capabilities, Emcure Pharmaceuticals works to discover and formulate medicines that address unmet medical needs and improve patient outcomes. The company’s research initiatives focus on areas such as complex generics, biosimilars, biologics, and specialized pharmaceutical formulations. These research efforts allow the organization to continuously introduce improved therapies and drug delivery systems designed to enhance treatment effectiveness and patient safety.
Company Leadership SM
DG
Getz Pharma is an international research-driven, branded generic pharmaceutical company specializing in the formulation, development, manufacturing and marketing of a wide range of quality, affordable medicines.
Company Leadership AS
MB
HA
Frequently Asked Questions Regarding PAI Pharma Top Executives and Leadership Team
